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A Pituitary Adenoma Secreting High Molecular Weight 
Adrenocorticotropin without Evidence of Cushing's 
Disease 
M. REINCKE, B. ALLOLIO, W. SAEGER, D. K A U L E N , AND W. WINKELMANN 
Medizinische Universitätsklinik II, Köln-Merheim, Köln; and Abteilung für Pathologie (W.S.), 
Marienkrankenhaus Hamburg, Hamburg, West Germany 
A B S T R A C T . We report a patient with hypersecretion of a 
high raol wt ACTH from an aggressive corticotropic pituitary 
tumor who did not have hypercortisolism. Basal plasma ACTH 
levels were clearly elevated (26-121 pmol/L), whereas basal and 
stimulated serum Cortisol levels were in the normal range. The 
pituitary source of the ACTH hypersecretion was confirmed by 
selective venous catheterization. Gel chromatography of the 
patient's plasma showed two peaks of ACTH immunoreactivity, 
one major peak eluting near the void volume (high mol wt form 
of ACTH), accounting for more than 95% of the ACTH detected, 
and a very small peak at the expected position of ACTH-(l-39). 
Plasma ACTH levels were not altered by metyrapone or bro-
mocriptine. During high dose dexamethasone administration 
plasma ACTH decreased, but was not fully suppressed. Immu-
nohistochemical evaluation of tumor tissue demonstrated ACTH 
immunoreactivity in 40% of the tumor cells. The patient died 
from postoperative complications after a second operation per-
formed after tumor recurrence. This patient's course confirms 
the observations of relatively rapid growth and high recurrence 
rate in clinically silent corticotropic pituitary adenomas. (J Clin 
Endocrinol Metab 65: 1296, 1987) 
AMONG surgically removed pituitary adenomas, ap-proximately 30-35% appear to be silent, unasso-
ciated with clinical or biochemical evidence of any an-
terior pituitary hormone excess (1, 2). However, with 
routine immunocytochemical staining of the pituitary 
tumor tissue, immunoreactive hormone material can be 
demonstrated in a substantial number of these seemingly 
nonfunctioning tumors (2). Clinically silent immuno-
reactive FSH- and LH-containing pituitary adenomas 
were reported by Trouillas et al. in 1981 (3). More re-
cently, silent pituitary adenomas secreting a-subunit 
have been described (4). Corticotropic pituitary adeno-
mas without evidence of Cushing's disease have been 
reported by Hassoun et al. in 1979 (5) and in more detail 
by Horvath et al. in 1980 (2). However, secretion of 
biologically inactive ACTH in patients with silent corti-
cotropic adenomas has not been described. We report 
here a patient with hypersecretion of immunoreactive 
ACTH from a clinically silent pituitary adenoma. 
Case Report 
A 46-yr-old man was admitted to the Städtische Kranken-
anstalten Köln-Merheim in May 1981 with a 6-month history 
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Address all correspondence and requests for reprints to: Dr. M . 
Reincke, Medizinische Universitätsklinik I I , Köln-Merheim, Ostmer-
heimer Str. 200, 5000 Köln 41, West Germany. 
of visual problems followed by decreased libido. The visual 
acuity in his left eye was diminished, but no temporal visual 
field defect was found. He was mildly obese (height 1.76 m; 
weight, 79 kg), but had no clinical features of hypercortisolism. 
Serum electrolytes were normal. Glucose tolerance (100 g glu-
cose, orally) was abnormal, with a fasting blood glucose level 
of 5.0 mmol/L and a 2-h value of 13.6 mmol/L. Skull x-rays 
showed an enlarged pituitary fossa. Computerized axial tomog-
raphy revealed an intrasellar tumor with suprasellar and para-
sellar extension. In July 1981 he underwent transfrontal cra-
niotomy, but only incomplete removal of the tumor was 
achieved. Postoperative recovery was uneventful, and his visual 
acuity returned to normal. Tumor recurrence necessitated a 
second operation in March 1983. He died from pulmonary 
embolism soon after surgery. At autopsy no carcinoma, i.e. 
bronchial carcinoma, or metastases were found. The weight of 
the adrenal glands was normal. 
Materials and Methods 
Assessment of hormonal status was performed before and 
after the first craniotomy. Plasma A C T H was measured in 
triplicate by R I A (6) after extraction with Q U S O (7). The 
antibody cross-reacted completely with A C T H - ( l - 2 4 ) , human 
(h) ACTH-(1-39) , and ACTH-(11-24) , and did not react with 
A C T H - ( l - l O ) , hACTH-(27-39), ßhMSH, or a h M S H . Plasma 
A C T H also was measured in duplicate by a highly specific two-
site immunoradiometric assay for h A C T H - ( l - 3 9 ) . This anti-
body did not react with h A C T H - ( l - 3 2 ) , A C T H - ( l - 2 4 ) , and 
hACTH-(18-39) (8). Plasma ^-endorphin was determined by 
1296 
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R I A after extraction with Vycor powder (9). The antibody had 
58% cross-reactivity with ß-lipotropin. Synthetic /^-endorphin 
(Universal Biologicals, Cambridge, United Kingdom) was used 
for standard and radioiodination. Urinary Cortisol excretion 
was determined after extraction and chromatography (10). The 
serum levels of other hormones were measured by standard 
R I A techniques using commercially available reagents. 
Analysis of the molecular size of the circulating immuno-
reactive A C T H was performed by gel chromatography, as de-
scribed by Ratter et al. (11). Acidified plasma was chromato-
graphed on a column of Sephadex G-75 (superfine; 100 x 1.5 
cm) equilibrated with 1% formic acid. 
Sections of the tumor tissue were examined by light micros-
copy using conventional and immunocytochemical techniques, 
described previously (12). Using the peroxidase-antiperoxidase 
method on paraffin-embedded sections, the following commer-
cial primary antibodies were tested: ant i -ACTH [synthetic 
0 A C T H - U - 2 3 ) , Ferring Arzneimittel, Wittland, West Ger-
many; dilution 1:200), ant i -ACTH (synthetic A C T H - ( l - 2 4 ) , 
Dakopatts, Hamburg, West Germany; 1:300), ant i -CRH (Me-
dac, Hamburg, West Germany; 1:20), anti-GH (Dakopatts; 
1:500), ant i -GH (Kabi vitrum, München, West Germany; 
1:100), a n t i - P R L (Dakopatts; 1:800), ant i -TSH (Kabi vitrum: 
München, West Germany 1:200), anti -FSH (Dakopatts; 1:200), 
and an t i -LH (Dakopatts; 1:800). Normal adenohypophysis and 
hypothalamus were used as control tissues for immunocyto-
chemistry. The three traditional types of control reactions, 
increase in dilution, omitting components, and antiserum 
preabsorption with antigen excess, were performed. 
Results 
Preoperatively, thyroid function was normal. Gonad-
otropin secretion in response to stimulation with GnRH 
was diminished, and serum testosterone was in the low 
normal range. Baseline serum PRL and the PRL re-
sponse to T R H were normal. Serum GH did not increase 
after insulin-induced hypoglycemia. 
No signs of adrenal hyperfunction were found. The 24-
h urinary Cortisol excretion was 69 nmol/day (normal, 
55-176 nmol/day). Baseline serum Cortisol as well as the 
Cortisol response to exogenous ACTH and insulin-in-
duced hypoglycemia were normal preoperatively (Table 
1). The serum Cortisol values displayed a normal diurnal 
variation (0900 h, 440; 1000 h, 360; 1100 h, 310; 1200 h, 
250; 1300 h, 220 nmol/L). Postoperatively, the response 
to insulin-induced hypoglycemia was impaired (peak 
serum Cortisol, 330 nmol/L), whereas the Cortisol re-
sponse to exogenous ACTH remained normal. 
In contrast, preoperative plasma radioimmunoassaya-
ble ACTH levels were clearly elevated (35-82 pmol/L at 
0900 h; normal range, <11 pmol/L). One month after the 
first operation, plasma ACTH was 50 pmol/L at 0900 h. 
It remained elevated (26-131 pmol/L at 0900 h), sug-
gesting the presence of a tumor secreting biologically 
inactive ACTH. Similarly, plasma /3-endorphin immu-
noreactivity was increased (3220 ng/L; normal, <230). 
While serum Cortisol was readily suppressed by dexa-
methasone, plasma ACTH immunoreactivity was ele-
vated throughout the test period, though it decreased 
from 131 to 50 pmol/L (Fig. 1). Thus, partial suppression 
of the secretion of biologically inactive ACTH together 
with complete suppression of biologically active ACTH, 
probably secreted by nontumorous cells, occurred. 
Plasma ACTH levels, measured at 0, 120, 180, 240, and 
300 min, did not change after metyrapone (2.0 g, iv) or 
bromocriptine (2.5 mg, orally) administration, demon-
strating autonomy of tumor peptide secretion, but in-
creased after lysine vasopressin (Table 1). 
Plasma ACTH measured by immunoradiometric assay 
(IRMA) was in the low normal range and increased 
slightly after lysine vasopressin administration (Table 
1), suggesting release of biologically active ACTH in the 
presence of a tumor secreting biologically inactive 
ACTH. 
To investigate the molecular size of the circulating 
biologically inactive ACTH, gel chromatography was per-
formed. Gel chromatography of plasma of an Addisonian 
patient revealed a single peak of immunoreactive ACTH 
(Fig. 2a), eluting at the same position as [ 1 2 5I]ACTH-(1-
39). The patient's plasma, fractionated under the same 
conditions, showed two peaks (Fig. 2b). A very small 
peak appeared at the expected position of ACTH-(l-39); 
the second, predominant peak, eluting near the void 
volume, indicated the presence of a large mol wt form of 
ACTH. This peak accounted for more than 95% of the 
ACTH detected. In contrast, the plasma of a patient with 
an ACTH-secreting bronchial carcinoma and Cushing's 
syndrome had a heterogenous, large mol wt peak (Fig. 
2c), indicating the release of a variety of peptides with 
different mol wt. 
To exclude ectopic ACTH secretion, selective venous 
sampling was performed. This procedure confirmed a 
pituitary source of the ACTH hypersecretion (gradient 
from high internal jugular vein to inferior vena cava, 1.4 
to 1). 
Histologically an undifferentiated mucoid cell ade-
noma was found. Very few mitoses and cells with two or 
more nuclei were seen. Periodic acid-Schiff staining re-
vealed a few strongly granulated cells and a large number 
of very slightly granulated cells. Immunohistochemical 
studies demonstrated ACTH immunoreactivity in 40% 
[anti-ACTH-(l-23); Fig. 3] or 15% [anti-ACTH-(1-24)] 
of the adenoma cells, whereas GH, PRL, and CRH were 
not detected. T S H and FSH were found in a few scattered 
cells. At autopsy, the adenoma invaded the capsule, the 
neurohypophysis, the sellar bone, and the sphenoid sinus. 
Little intact adenohypophyseal tissue was found, and it 
contained different cell types and very few immunoreac-
tive ACTH-containing cells with partial hyalinization. 
Fully developed Crook's cells were not found. 
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TABLE 1. Preoperative serum Cortisol and/or plasma A C T H ( R I A and I R M A ) responses at 0900 h to exogenous A C T H (250 jug, iv), insulin-
induced hypoglycemia (0.15 IU/kg) , and lysine vasopressin administration (5 I U , iv, for 60 min) 
Time (min) 
Response to ACTH: 
Cortisol 
(nmol/L) 
Response to 
insulin-induced hypoglycemia: 
Cortisol 
(nmol/L) 
ACTH (RIA; 
pmol/L) 
Response to 
lysine vasopressin: 
ACTH (IRMA; 
pmol/L) 
Cortisol 
(nmol/ 
L) 
0 350 410 96 5 290 
15 143 6 500 
30 960 480 114 6 790 
45 940 118 7 820 
60 1160 980 89 7 820 
90 1250 880 83 6 550 
Normal basal (0900 h) values: serum Cortisol, 140-690 nmol/L; ACTH (RIA and IRMA), <11 pmol/L. 
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FIG. 1. Serum Cortisol and plasma ACTH (RIA) concentrations during 
administration of dexamethasone. 
Discussion 
The major finding in this patient was the secretion of 
a high mol wt form of ACTH by a pituitary adenoma in 
the absence of hypercortisolism. Clinically, the large 
pituitary tumor resulted in impairment of visual acuity 
and acquired hypogonadism. Baseline and stimulated 
serum Cortisol levels were in the normal range. The 
finding of clearly elevated basal immunoradioassayable 
ACTH was unexpected in this patient, who initially was 
diagnosed as having a nonfunctioning chromophobe ad-
PLASMA ACTH 
( p m o l / t ) 50 
25-
100 120 HO 160 CmG 
ELUTION VOLUME 
FIG. 2. Gel filtration patterns of plasma ACTH obtained (b) from our 
patient (b), a patient with Addison's disease (a), and a patient with the 
ectopic ACTH syndrome due to a bronchial carcinoma (c). VG, Void 
volume. 
enoma. Gel chromatography demonstrated that a high 
mol wt form of ACTH accounted for more than 95% of 
the immunoreactive ACTH detected. After incomplete 
removal of the tumor, ACTH levels remained elevated. 
The tumor recurred within 18 months, demonstrating 
the aggressive nature of the tumor. 
ACTH and related peptides are produced and secreted 
by pituitary tumors in the context of Cushing's disease 
(13) and by extrapituitary tumors (ectopic ACTH-pro-
ducing tumors) (14). Beside the main feature of hyper-
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FIG. 3. Immunostaining for ACTH [anti-ACTH-(1-23)]. ACTH-pos-
itive granules are most prominently seen in the periphery of many 
adenoma cells. Anti-ACTH, peroxidase-antiperoxidase, diamino-ben-
zidine. Magnification, X670. 
cortisolism, abnormalities in the processing of the ACTH 
precursors have been found, resulting in the secretion of 
various large molecular forms of ACTH (15). These large 
forms of ACTH appear to be more typical of the ectopic 
ACTH syndrome (11). While there are a few recent 
reports of big ACTH secretion by aggressive pituitary 
adenomas in patients with Cushing's disease (14, 16-18), 
the production of big ACTH by a silent corticotropic 
pituitary adenoma has not been previously reported. 
Silent corticotropic adenomas unassociated with clin-
ical and biochemical signs of hormone overproduction 
have been well described. Such tumors were classified as 
chromophobe adenomas by conventional staining tech-
niques, but contained immunoreactive ACTH (2, 5). In 
the series described by Horvath et al. (2) 43% of all 
corticotropic tumors were not associated with clinical 
signs of Cushing's disease, and 9 of 14 tumors examined 
histologically were of the chromophobe type. These tu-
mors have several features in common with that in our 
patient, notably a relatively rapid growth rate and a high 
recurrence rate. 
The cause of "silence" in these adenomas appears 
complex. In some tumors it has been attributed to failure 
of exocytosis of hormone from the cell membrane and to 
an increase in intracellular disposal by lysosomes (19). 
In other tumors, examination by electron microscopy 
suggested defective packaging of ACTH into secretory 
granules due to an inadequately developed Golgi complex 
(2). In our patient the cause appears to be incomplete or 
aberrant processing of proopiomelanocortin (POMC), 
the large precursor of ACTH, and, thus, failure to pro-
duce biologically active hormone. POMC is a 31,000-
dalton glycoprotein and contains ACTH and ß-lipotropin 
in its carboxy-terminal portion and an N-terminal pro-
tein of 16,000 daltons (pro-7MSH). Production of ACTH 
and related peptides involves an intermediate step, 
wherein the C-terminal ß-lipotropin is cleaved, followed 
by the cleavage of ACTH (20). In ectopic ACTH-produc-
ing tumors and less prominently in pituitary adenomas 
several abnormalities in the biosynthesis and processing 
of ACTH have been reported (21). In a report of ectopic 
ACTH production, cleavage of the N-terminal peptide 
from ACTH/ß-lipotropin preceded cleavage between ß-
lipotropin and ACTH (22). In our patient, the increase 
in ß-endorphin/ß-lipotropin immunoreactivity in the 
presence of big ACTH in plasma may be due to a simi-
larly abnormal ACTH/ß-lipotropin peptide. Otherwise, 
elevated ß-endorphin/ß-lipotropin immunoreactivity may 
be explained by the secretion of ß-endorphin/ß-lipotro-
pin and big ACTH simultaneously. 
In patients with Cushing's syndrome due to a pituitary 
adenoma, ACTH responsiveness to vasopressin, metyr-
apone, bromocriptine, and dexamethasone persists, al-
though it is quantitatively abnormal (13). In contrast, 
this man had poorly autonomous secretion of big ACTH. 
There was no response to bromocriptine or metyrapone, 
while plasma ACTH levels decreased somewhat during 
high dose dexamethasone. These abnormalities reflect 
the relative autonomy of the tumor. 
The source of bioactivity in Cushing's syndrome with 
secretion of various molecular forms of ACTH is uncer-
tain (16,17). The bioactivity in the large mol wt fractions 
from ectopic tumors is assumed to be low (17). This 
patient's plasma contained big ACTH, which accounted 
for more than 95% of the detected immunoreactive 
ACTH. In the presence of normal serum Cortisol levels 
and normal 24-h Cortisol excretion this high mol wt form 
of ACTH probably had no or very little bioactivity. 
In conclusion, this patient again demonstrates that 
abnormalities of POMC processing and secretion are not 
a unique feature of the ectopic ACTH syndrome. His 
illness confirms the observation of relatively rapid 
growth and high recurrence rates in silent corticotropic 
adenomas. In such patients with silent pituitary adeno-
mas, screening for high mol wt ACTH should, therefore, 
be performed. 
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